Danske Bank’s Bristol-Myers Squibb BMY Stock Holding History

Danske Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.5M	Buy	1,501,133 +55,509	+4%	+$3.19M	0.17%	106
2026 Q1	$87.7M	Buy	1,445,624 +223,921	+18%	+$13.1M	0.21%	90
2025 Q4	$65.9M	Sell	1,221,703 -365,674	-23%	-$17.6M	0.15%	120
2025 Q3	$71.6M	Buy	1,587,377 +262,685	+20%	+$12.3M	0.18%	103
2025 Q2	$61.3M	Sell	1,324,692 -327,066	-20%	-$16.1M	0.15%	122
2025 Q1	$101M	Buy	1,651,758 +111,006	+7%	+$6.47M	0.31%	53
2024 Q4	$87.1M	Buy	1,540,752 +494,973	+47%	+$27.7M	0.26%	64
2024 Q3	$54.1M	Buy	1,045,779 +140,990	+16%	+$6.61M	0.18%	102
2024 Q2	$37.6M	Sell	904,789 -162,975	-15%	-$7.29M	0.14%	131
2024 Q1	$57.9M	Buy	+1,067,764	New	+$54.4M	0.18%	106

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Danske Bank's BMY Position: Q2 2026 in Review

Danske Bank increased its Bristol-Myers Squibb (BMY) stake by 3.8% in Q2 2026, buying an estimated $3.19M and bringing the position to 1,501,133 shares worth $86.5M. The position accounts for 0.17% of the portfolio, ranked #106.

Danske Bank first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $101M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Danske Bank held 1,501,133 shares of Bristol-Myers Squibb worth $86.5M as of Q2 2026.
Danske Bank bought 55,509 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.19M.
Bristol-Myers Squibb made up 0.17% of Danske Bank's portfolio in Q2 2026, its #106 holding.
Danske Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Danske Bank's Bristol-Myers Squibb position peaked at $101M in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.